デフォルト表紙
市場調査レポート
商品コード
1732896

ピーナッツアレルギー治療市場-世界の産業規模、シェア、動向、機会、予測、薬剤クラス別、投与経路別、流通チャネル別、地域別、競合別、2020年～2030年

Peanut Allergy Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class, By Route of Administration, By Distribution Channel, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 180 Pages
納期
2～3営業日
カスタマイズ可能
ピーナッツアレルギー治療市場-世界の産業規模、シェア、動向、機会、予測、薬剤クラス別、投与経路別、流通チャネル別、地域別、競合別、2020年～2030年
出版日: 2025年05月23日
発行: TechSci Research
ページ情報: 英文 180 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

ピーナッツアレルギー治療の世界市場は、2024年に5億8,610万米ドルと評価され、予測期間中に12.84％のCAGRを記録し、2030年までには12億1,020万米ドルに達すると予測されています。

ピーナッツアレルギーに対する意識の高まりと技術の進歩が、この市場の大きな成長を促進しています。ピーナッツアレルギーは生命を脅かす疾患であり、世界的に数百万人が罹患し続けているため、効果的な治療オプションに対する需要が急増しています。アレルギーのメカニズムに関する科学的な理解が深まったことで、アレルゲン特異的免疫療法や遺伝子ベースの治療といった標的治療の開発が可能になりました。同市場は、革新的かつ救命的な治療ソリューションに対するニーズの高まりに対応するため、研究開発に大規模な投資を行っている製薬企業や研究機関から注目を集めています。

市場概要
予測期間 2026年～2030年
市場規模：2024年 5億8,610万米ドル
市場規模：2030年 12億1,020万米ドル
CAGR：2025年～2030年 12.84%
急成長セグメント 経口
最大市場 北米

主要な市場促進要因

ピーナッツアレルギーの有病率の上昇

主要な市場課題

治療費の高騰

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のピーナッツアレルギー治療市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 薬剤クラス別（抗ヒスタミン薬、エピネフリン、免疫療法薬、その他）
    • 投与経路別（経口、静脈内、その他）
    • 流通チャネル別（小売薬局、病院薬局、オンライン薬局）
    • 地域別
    • 企業別（2024年）
  • 製品マップ
    • 薬剤クラス別
    • 投与経路別
    • 流通チャネル別
    • 地域別

第6章 北米のピーナッツアレルギー治療市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州のピーナッツアレルギー治療市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋のピーナッツアレルギー治療市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米のピーナッツアレルギー治療市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのピーナッツアレルギー治療市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • 製品上市

第13章 世界のピーナッツアレルギー治療市場：SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Vedanta Biosciences, Inc.
  • Alladapt Immunotherapeutics, Inc.
  • Regeneron Pharmaceuticals Inc.
  • Aravax Pty Ltd
  • Teva Pharmaceutical Industries Limited
  • Prota Therapeutics Pty Ltd.
  • Aimmune Therapeutics, Inc.（Nestle）
  • DBV Technologies SA
  • Sanofi SA
  • Mylan N.V.

第16章 戦略的提言

第17章 調査会社について・免責事項

目次
Product Code: 15257

The Global Peanut Allergy Treatment Market was valued at USD 586.10 million in 2024 and is projected to reach USD 1210.20 million by 2030, registering a CAGR of 12.84% during the forecast period. The rising awareness about peanut allergies, coupled with technological advancements, is driving significant growth in this market. Peanut allergy is a life-threatening condition that continues to affect millions globally, prompting a surge in demand for effective treatment options. Improved scientific understanding of allergy mechanisms has enabled the development of targeted therapies such as allergen-specific immunotherapy and gene-based treatments. The market has garnered attention from pharmaceutical companies and research organizations that are investing extensively in R&D to capitalize on the growing need for innovative and life-saving treatment solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 586.10 Million
Market Size 2030USD 1210.20 Million
CAGR 2025-203012.84%
Fastest Growing SegmentOral
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Peanut Allergies

The global rise in peanut allergy cases is a major factor accelerating growth in the peanut allergy treatment market. In Western countries, incidence rates have risen sharply over the last two decades. For example, the prevalence among U.S. children grew from 0.4% in 1997 to 1.4% by 2008, while the UK saw childhood food allergies triple from 1.2% to 4% between 2008 and 2018. This increase has intensified the demand for effective therapeutic solutions. Health authorities such as the CDC have flagged food allergies as a mounting public health concern, advocating for improved diagnostic and treatment frameworks. Parental concern and awareness regarding severe allergic reactions have spurred a push for more advanced interventions. As a result, pharmaceutical companies are intensifying efforts to develop treatments like biologics and immunotherapies to address this critical health issue, further propelling market expansion.

Key Market Challenges

High Cost of Treatment

The high cost associated with peanut allergy therapies remains a major challenge for market penetration and equitable access. Treatments such as immunotherapy and biologics involve high expenses related to drug formulation, administration, monitoring, and managing side effects. These costs may be prohibitive, especially in areas with limited insurance coverage or healthcare funding. Coverage discrepancies in insurance plans exacerbate affordability issues, discouraging patients from pursuing potentially effective care. Public healthcare systems also face budgetary pressures due to the high treatment costs. Overcoming this barrier requires cooperation among pharmaceutical companies, insurers, and government bodies. Implementing measures such as value-based pricing, enhanced insurance reimbursement, and patient support programs is essential to broaden treatment accessibility.

Key Market Players

  • Vedanta Biosciences, Inc.
  • Alladapt Immunotherapeutics, Inc.
  • Regeneron Pharmaceuticals Inc.
  • Aravax Pty Ltd
  • Teva Pharmaceutical Industries Limited
  • Prota Therapeutics Pty Ltd.
  • Aimmune Therapeutics, Inc. (Nestle)
  • DBV Technologies SA
  • Sanofi SA
  • Mylan N.V.

Report Scope:

In this report, the Global Peanut Allergy Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Peanut Allergy Treatment Market, By Drug Class:

  • Antihistamines
  • Epinephrine
  • Immunotherapies
  • Others

Peanut Allergy Treatment Market, By Route of Administration:

  • Oral
  • Intravenous
  • Others

Peanut Allergy Treatment Market, By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Peanut Allergy Treatment Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Peanut Allergy Treatment Market.

Available Customizations:

Global Peanut Allergy Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Peanut Allergy Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Drug Class (Antihistamines, Epinephrine, Immunotherapies, Others)
    • 5.2.2. By Route of Administration (Oral, Intravenous, Others)
    • 5.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Product Map
    • 5.3.1. By Drug Class
    • 5.3.2. By Route of Administration
    • 5.3.3. By Distribution Channel
    • 5.3.4. By Region

6. North America Peanut Allergy Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Drug Class
    • 6.2.2. By Route of Administration
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Peanut Allergy Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Drug Class
        • 6.3.1.2.2. By Route of Administration
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Peanut Allergy Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Drug Class
        • 6.3.2.2.2. By Route of Administration
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Peanut Allergy Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Drug Class
        • 6.3.3.2.2. By Route of Administration
        • 6.3.3.2.3. By Distribution Channel

7. Europe Peanut Allergy Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Drug Class
    • 7.2.2. By Route of Administration
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Peanut Allergy Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Drug Class
        • 7.3.1.2.2. By Route of Administration
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. Germany Peanut Allergy Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Drug Class
        • 7.3.2.2.2. By Route of Administration
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Peanut Allergy Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Drug Class
        • 7.3.3.2.2. By Route of Administration
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Peanut Allergy Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Drug Class
        • 7.3.4.2.2. By Route of Administration
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Peanut Allergy Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Drug Class
        • 7.3.5.2.2. By Route of Administration
        • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Peanut Allergy Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Drug Class
    • 8.2.2. By Route of Administration
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Peanut Allergy Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Drug Class
        • 8.3.1.2.2. By Route of Administration
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Peanut Allergy Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Drug Class
        • 8.3.2.2.2. By Route of Administration
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Peanut Allergy Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Drug Class
        • 8.3.3.2.2. By Route of Administration
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Peanut Allergy Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Drug Class
        • 8.3.4.2.2. By Route of Administration
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Peanut Allergy Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Drug Class
        • 8.3.5.2.2. By Route of Administration
        • 8.3.5.2.3. By Distribution Channel

9. South America Peanut Allergy Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Drug Class
    • 9.2.2. By Route of Administration
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Peanut Allergy Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Drug Class
        • 9.3.1.2.2. By Route of Administration
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Argentina Peanut Allergy Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Drug Class
        • 9.3.2.2.2. By Route of Administration
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. Colombia Peanut Allergy Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Drug Class
        • 9.3.3.2.2. By Route of Administration
        • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Peanut Allergy Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Drug Class
    • 10.2.2. By Route of Administration
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Peanut Allergy Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Drug Class
        • 10.3.1.2.2. By Route of Administration
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Saudi Arabia Peanut Allergy Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Drug Class
        • 10.3.2.2.2. By Route of Administration
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. UAE Peanut Allergy Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Drug Class
        • 10.3.3.2.2. By Route of Administration
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Peanut Allergy Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Vedanta Biosciences, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Alladapt Immunotherapeutics, Inc.
  • 15.3. Regeneron Pharmaceuticals Inc.
  • 15.4. Aravax Pty Ltd
  • 15.5. Teva Pharmaceutical Industries Limited
  • 15.6. Prota Therapeutics Pty Ltd.
  • 15.7. Aimmune Therapeutics, Inc. (Nestle)
  • 15.8. DBV Technologies SA
  • 15.9. Sanofi SA
  • 15.10. Mylan N.V.

16. Strategic Recommendations

17. About Us & Disclaimer